Ferroptosis Plays a Pivotal Role in Activating and Modulating Specific Intracellular Signaling Pathways Integrated into the Therapeutic Management of Colorectal Cancer

Overview

Journal Int J Mol Cell Med

Date 2025 Feb 3

PMID 39895914

Authors

Marzieh Monemi

Hanan Hassan Ahmed

Radhwan Abdul Kareem

Waam Mohammed Taher

Mariem Alwan

Mahmood Jasem Jawad

Atheer Khdyair Hamad

Samaneh Moradi

Affiliations

Soon will be listed here.

Abstract

It is expected that the amount of recently diagnosed colon cancer cases will increase to around 3.2 million yearly until 2040. Although early diagnostic procedures and management approaches have been improved, colorectal cancer (CRC) treatment remains challenging. There is an urgent need to discover new therapeutic agents to enhance therapeutic strategies. Ferroptosis is distinguished as a mode of regulated cell death considered by iron-dependent lipid peroxidation. Contemporary investigations suggest that induction of ferroptosis in CRC can effectively target neoplastic cells that are resistant to alternative forms of cell death. This review has summarized recent scientific work on the implications of ferroptosis in CRC treatment and highlights its underlying molecular and biological mechanisms. While investigating its therapeutic potential, it shows the importance of diverse modulators of ferroptosis, including the 7-membered solute carrier family 11 or xCT (SLC7A11), reactive oxygen species (ROS), glutathione (GSH), and iron in the context of CRC. Recent research has identified specific pathways and compounds that can induce ferroptosis in CRC, such as apatinib and elesclimol, which are involved in pivotal signaling cascades. Attenuation of proteins such as splicing factor, arginine/serine 9 (SFRS9), and Tp53-induced glycolysis and apoptosis regulator (TIGAR) may increase the sensitivity of CRC cells to ferroptosis, thus suggesting promising therapeutic avenues. Compounds including IMCA and β-elemene have shown efficacy in inducing ferroptosis while minimizing toxicity to normal tissues, thereby demonstrating their potential as therapeutic agents for CRC. Participating ferroptosis stimulator drugs with current treatment regimens, such as cetuximab and aspirin, may offer better treatment outcomes for CRC patients, especially those presenting resistance to conventional therapies.

References

Xu X, Zhang X, Wei C, Zheng D, Lu X, Yang Y . Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis. Eur J Pharm Sci. 2020; 152:105450. DOI: 10.1016/j.ejps.2020.105450. View

Garcia-Foncillas J, Sunakawa Y, Aderka D, Wainberg Z, Ronga P, Witzler P . Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors. Front Oncol. 2019; 9:849. PMC: 6763619. DOI: 10.3389/fonc.2019.00849. View

Pastushenko I, Blanpain C . EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 2018; 29(3):212-226. DOI: 10.1016/j.tcb.2018.12.001. View

Gao M, Fan K, Chen Y, Zhang G, Chen J, Zhang Y . Understanding the mechanistic regulation of ferroptosis in cancer: the gene matters. J Genet Genomics. 2022; 49(10):913-926. DOI: 10.1016/j.jgg.2022.06.002. View

Sun J, Cheng X, Pan S, Wang L, Dou W, Liu J . Dichloroacetate attenuates the stemness of colorectal cancer cells via trigerring ferroptosis through sequestering iron in lysosomes. Environ Toxicol. 2020; 36(4):520-529. DOI: 10.1002/tox.23057. View

Ohmori H, Fujii K, Kadochi Y, Mori S, Nishiguchi Y, Fujiwara R . Elaidic Acid, a Trans-Fatty Acid, Enhances the Metastasis of Colorectal Cancer Cells. Pathobiology. 2016; 84(3):144-151. DOI: 10.1159/000449205. View

Li R, Wu Y, Li Y, Shuai W, Wang A, Zhu Y . Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms. Eur J Med Chem. 2023; 265:116040. DOI: 10.1016/j.ejmech.2023.116040. View

Zhang L, Liu W, Liu F, Wang Q, Song M, Yu Q . IMCA Induces Ferroptosis Mediated by SLC7A11 through the AMPK/mTOR Pathway in Colorectal Cancer. Oxid Med Cell Longev. 2020; 2020:1675613. PMC: 7160732. DOI: 10.1155/2020/1675613. View

Viswanathan V, Ryan M, Dhruv H, Gill S, Eichhoff O, Seashore-Ludlow B . Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017; 547(7664):453-457. PMC: 5667900. DOI: 10.1038/nature23007. View

10.

Ma W, Hu N, Xu W, Zhao L, Tian C, Kamei K . Ferroptosis inducers: A new frontier in cancer therapy. Bioorg Chem. 2024; 146:107331. DOI: 10.1016/j.bioorg.2024.107331. View

11.

Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G . Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov. 2021; 7(1):193. PMC: 8313570. DOI: 10.1038/s41420-021-00579-w. View

12.

Fujii K, Luo Y, Fujiwara-Tani R, Kishi S, He S, Yang S . Pro-metastatic intracellular signaling of the elaidic trans fatty acid. Int J Oncol. 2016; 50(1):85-92. DOI: 10.3892/ijo.2016.3797. View

13.

Arranz A, Doxaki C, Vergadi E, Martinez De La Torre Y, Vaporidi K, Lagoudaki E . Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization. Proc Natl Acad Sci U S A. 2012; 109(24):9517-22. PMC: 3386059. DOI: 10.1073/pnas.1119038109. View

14.

Feng S, Tang D, Wang Y, Li X, Bao H, Tang C . The mechanism of ferroptosis and its related diseases. Mol Biomed. 2023; 4(1):33. PMC: 10577123. DOI: 10.1186/s43556-023-00142-2. View

15.

Chen H, Qi Q, Wu N, Wang Y, Feng Q, Jin R . Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. Redox Biol. 2022; 55:102426. PMC: 9389304. DOI: 10.1016/j.redox.2022.102426. View

16.

Ma T, Du J, Zhang Y, Wang Y, Wang B, Zhang T . GPX4-independent ferroptosis-a new strategy in disease's therapy. Cell Death Discov. 2022; 8(1):434. PMC: 9617873. DOI: 10.1038/s41420-022-01212-0. View

17.

Slattery M, Herrick J, Mullany L, Samowitz W, Sevens J, Sakoda L . The co-regulatory networks of tumor suppressor genes, oncogenes, and miRNAs in colorectal cancer. Genes Chromosomes Cancer. 2017; 56(11):769-787. PMC: 5597468. DOI: 10.1002/gcc.22481. View

18.

Li F, Long H, Zhou Z, Luo H, Xu S, Gao L . System X /GSH/GPX4 : An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol. 2022; 13:910292. PMC: 9465090. DOI: 10.3389/fphar.2022.910292. View

19.

Xu C, Li S, Chen J, Wang H, Li Z, Deng Q . Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy. J Control Release. 2023; 356:256-271. DOI: 10.1016/j.jconrel.2023.03.001. View

20.

Summers M, Smith C, Maughan T, Kaplan R, Escott-Price V, Cheadle J . and Locus-Specific Variants Have Different Outcomes on Survival to Colorectal Cancer. Clin Cancer Res. 2016; 23(11):2742-2749. DOI: 10.1158/1078-0432.CCR-16-1541. View